Reregulated mitochondrial dysfunction reverses cisplatin resistance microenvironment in colorectal cancer

Yonghui Wang; Xiaodong Ma; Wenhui Zhou; Chang Liu; Hongbo Zhang

doi:10.1002/SMMD.20220013

Reregulated mitochondrial dysfunction reverses cisplatin resistance microenvironment in colorectal cancer

Yonghui Wang, Xiaodong Ma, Wenhui Zhou, Chang Liu, Hongbo Zhang^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Smart Medicine
DOIs	https://doi.org/10.1002/SMMD.20220013
Publication status	Published - 22 Dec 2022
MoE publication type	A1 Journal article-refereed

Access to Document

10.1002/SMMD.20220013

Cite this

@article{d0bfca7b25a5413db4cf122325e1c6a5,

title = "Reregulated mitochondrial dysfunction reverses cisplatin resistance microenvironment in colorectal cancer",

author = "Yonghui Wang and Xiaodong Ma and Wenhui Zhou and Chang Liu and Hongbo Zhang",

year = "2022",

month = dec,

day = "22",

doi = "10.1002/SMMD.20220013",

language = "English",

journal = "Smart Medicine",

issn = "2751-1871",

publisher = "Wiley Open Access",

}

TY - JOUR

T1 - Reregulated mitochondrial dysfunction reverses cisplatin resistance microenvironment in colorectal cancer

AU - Wang, Yonghui

AU - Ma, Xiaodong

AU - Zhou, Wenhui

AU - Liu, Chang

AU - Zhang, Hongbo

PY - 2022/12/22

Y1 - 2022/12/22

UR - https://doi.org/10.1002/SMMD.20220013

U2 - 10.1002/SMMD.20220013

DO - 10.1002/SMMD.20220013

M3 - Article

JO - Smart Medicine

JF - Smart Medicine

SN - 2751-1871

ER -

Reregulated mitochondrial dysfunction reverses cisplatin resistance microenvironment in colorectal cancer

Access to Document

Other files and links

FCFH: Finland-China Network in Food and Health Sciences

Targeted delivery of CRISPR/Cas9 for advanced liver cancer therapy through c-Myc knockout

Cite this

Reregulated mitochondrial dysfunction reverses cisplatin resistance microenvironment in colorectal cancer

Access to Document

Other files and links

Projects

FCFH: Finland-China Network in Food and Health Sciences

Targeted delivery of CRISPR/Cas9 for advanced liver cancer therapy through c-Myc knockout

Cite this